These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19963331)

  • 1. How was patient empowerment portrayed in information leaflets describing the community pharmacy Medicines Use Review service in the UK?
    van den Berg M; Donyai P
    Patient Educ Couns; 2010 Aug; 80(2):274-6. PubMed ID: 19963331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the patient perspective of the English community pharmacy Medicines Use Review (MUR).
    Latif A; Boardman HF; Pollock K
    Res Social Adm Pharm; 2013; 9(6):949-57. PubMed ID: 23506650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community pharmacists' perspectives on implementation of Medicines Use Review in Slovenia.
    Nabergoj Makovec U; Kos M; Pisk N
    Int J Clin Pharm; 2018 Oct; 40(5):1180-1188. PubMed ID: 29909563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of the Medicines Use Review (MUR) consultation to counseling practice in community pharmacies.
    Latif A; Pollock K; Boardman HF
    Patient Educ Couns; 2011 Jun; 83(3):336-44. PubMed ID: 21621943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised evaluation of the Italian medicines use review provided by community pharmacists using asthma as a model (RE I-MUR).
    Manfrin A; Thomas T; Krska J
    BMC Health Serv Res; 2015 Apr; 15():171. PubMed ID: 25896873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacist led medication reviews in the UK: A scoping review of the medicines use review and the new medicine service literatures.
    Stewart D; Whittlesea C; Dhital R; Newbould L; McCambridge J
    Res Social Adm Pharm; 2020 Feb; 16(2):111-122. PubMed ID: 31085141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance and concordance during domiciliary medication review involving pharmacists and older people.
    Salter C
    Sociol Health Illn; 2010 Jan; 32(1):21-36. PubMed ID: 19891619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries.
    Svensberg K; Sporrong SK; Björnsdottir I
    Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient opinions on medicine-use review: exploring an expanding role of community pharmacists.
    Aimaurai S; Jumpated A; Krass I; Dhippayom T
    Patient Prefer Adherence; 2017; 11():751-760. PubMed ID: 28435233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistency and replicability of a pharmacist-led intervention for asthma patients: Italian Medicines Use Review (I-MUR).
    Manfrin A; Krska J
    Prim Health Care Res Dev; 2019 Jan; 20():e10. PubMed ID: 30208976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: a multi-method study.
    Bradley F; Wagner AC; Elvey R; Noyce PR; Ashcroft DM
    Health Policy; 2008 Dec; 88(2-3):258-68. PubMed ID: 18468713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conceptualizing and measuring pharmacist-patient communication: a review of published studies.
    Shah B; Chewning B
    Res Social Adm Pharm; 2006 Jun; 2(2):153-85. PubMed ID: 17138507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' willingness to use a pharmacist-provided medication management service: the influence of outcome expectancies and communication efficacy.
    Carter SR; Moles R; White L; Chen TF
    Res Social Adm Pharm; 2012; 8(6):487-98. PubMed ID: 22381916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring patient expectations for pharmacist-provided literacy-sensitive communication.
    Collum JL; Marcy TR; Stevens EL; Burns CF; Miller MJ
    Res Social Adm Pharm; 2013; 9(5):626-32. PubMed ID: 22835713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008.
    Lee E; Braund R; Tordoff J
    N Z Med J; 2009 Apr; 122(1293):3566. PubMed ID: 19448788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
    Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
    Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand.
    Hatah E; Tordoff J; Duffull SB; Cameron C; Braund R
    Int J Clin Pharm; 2014 Jun; 36(3):503-12. PubMed ID: 24626968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressed patients' preferences for education about medications by pharmacists in Kuwait.
    Al-Saffar N; Abdulkareem A; Abdulhakeem A; Salah AQ; Heba M
    Patient Educ Couns; 2008 Jul; 72(1):94-101. PubMed ID: 18337052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conceptual framework of patient satisfaction with a pharmacy adherence service.
    van den Berg M; Donyai P
    Int J Clin Pharm; 2014 Feb; 36(1):182-91. PubMed ID: 24306435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.